Hidden mutations in immune cells linked to autoimmune disease
On Apr. 14, 2026, researchers from the Wellcome Sanger Institute, Cambridge University Hospitals NHS Foundation Trust (CUH), the…
-
-
Biotechnology | Diagnostics | Genomics | Infectious Disease | Medicine | Nanotechnology | Neurology | NIH | Non-Profit Research | Oncology | Pharmaceutical | Rare Disease | Stem Cell | Therapeutics | U.S. Congress | Vaccine | Women's Health
Trump administration drops court fight to cap NIH payments for research overhead costs
On Apr. 8, 2026, the Trump administration will not be asking the Supreme Court to take up its…
-
Gilead to Acquire Tubulis for $5 Billion to Further Strengthen Oncology Pipeline
On Apr. 7, 2026, Gilead Sciences announced it has entered into a definitive agreement to acquire Tubulis, a…
-
Cornell Scientists take big step toward safe, reversible male contraception
On Apr. 7, 2026, Cornell scientists announce they have taken a major step toward developing a safe, reversible,…
-
Agriculture | Biotechnology | Diagnostics | Infectious Disease | Medical Device | Neurology | NIH | Non-Profit Research | Oncology | Pharmaceutical | Stem Cell | Therapeutics | U.S. Congress | Vaccine | Veterinary | Women's Health
Life Science Industry’s Rapid Growth in Washington State Challenged by NIH Budget Cuts
On Apr. 7, 2026, LifeScienceHistory.com, formerly WashingtonLifeScience.com, announces release of a report highlighting the challenges of Washington State’s…
-
FDA approves Lilly’s Foundayo™ (orforglipron), the only GLP-1 pill for weight loss that can be taken any time of day without food or water restrictions
On Apr. 1, 2026, Eli Lilly announced the U.S. Food and Drug Administration (FDA) approved Foundayo™ (orforglipron) for…
-
Artificial Intelligence | Biotechnology | Cloning | CRISPR | Diagnostics | Genomics | Implants | Infectious Disease | Life Science History | Medical Device | Nanotechnology | Neurology | NIH | Non-Profit Research | Pharmaceutical | Quantum | Therapeutics | U.S. Congress
China Tops U.S. in R&D Spending
On Mar. 31, 2026, the Organisation for Economic Co-operation and Development (OECD), reports that China has officially crept…
-
Biogen to Acquire Apellis for $5.6 billion, Enhancing the Company’s Growth Portfolio in Immunology and Rare Disease
On Mar. 31, 2026, Biogen and Apellis Pharmaceuticals announced the companies have entered into a definitive agreement under…
-
Biotechnology | Disease | FDA | Therapeutics
FDA Approves New High Dose Regimen of SPINRAZA® (nusinersen) for Spinal Muscular Atrophy
On Mar. 30, 2026, Biogen announced that the High Dose Regimen of SPINRAZA® (nusinersen), which is comprised of…
-
Artificial Intelligence | Biotechnology | Diagnostics | Infectious Disease | Medical Device | Neurology | Pharmaceutical | Therapeutics
China biotech deals hit record as innovative drugs draw interest of multinationals
On Mar. 29, 2026, The South China Morning Post reported the cross-border outlicensing activities of Chinese biotech firms…
-
Insilico Medicine secures $2.75 billion drug collaboration with Eli Lilly
On Mar. 29, 2026, generative-AI drug developer Insilico Medicine announced that it has agreed to a global licensing…
-
Biotechnology | Clinical Research | Diagnostics | Environmental | Infectious Disease | NIH | Non-Profit Research | Rare Disease | Therapeutics | Vaccine
NIH restrictions on foreign research partnerships significantly impacted 1 in 4 U.S. scientists
On Mar. 27, 2026, a STAT survey conducted of nearly 1,000 National Institutes of Health (NIH) -supported scientists,…
-
Novartis to acquire Excellergy for $2 Billion, building on allergy leadership with next-generation anti-IgE innovation
On Mar. 27, 2026, Novartis announced an agreement to acquire Excellergy, a private biotech company developing next-generation anti-IgE…
-
Implantable ‘Living Pharmacy’ Produces Multiple Drugs Inside the Body
On Mar. 27, 2026, A multi-institutional team of scientists, co-led by Northwestern University, has taken a crucial step…
-
New enzyme atlas rewrites decades of biology research
On Mar. 23, 2026, The Walter and Eliza Hall Institute of Medical Research (WEHI) researchers have led a…
-
Novartis to acquire a pan-mutant-selective PI3Kα inhibitor, strengthening its breast cancer pipeline for $3 Billion
On Mar. 20, 2026, Novartis announced an agreement with Synnovation Therapeutics, to acquire SNV4818, a pan-mutant‑selective PI3Kα inhibitor,…
-
Biotechnology | Disease | FDA | Therapeutics
FDA approves new higher-dose version of Wegovy shots
On Mar. 19, 2026, The U.S. Food and Drug Administration approved a 7.2-milligram dose of Danish drugmaker Novo…
-
Agriculture | Artificial Intelligence | Biotechnology | Diagnostics | Environmental | FDA | Genomics | Imaging | Infectious Disease | Medical Device | Medicine | Nanotechnology | Neurology | NIH | Non-Profit Research | Oncology | Pharmaceutical | Therapeutics | U.S. Congress | Vaccine | Veterinary | Women's Health
National survey of NIH-funded researchers shows precarious state of U.S. science — ‘This is like the Titanic’
On Mar. 19, 2026, a nationwide STAT survey of federally funded researchers reveals that, a year after Donald…
-
Biotechnology | Cardiology | Diagnostics | FDA | Neurology | NIH | Rare Disease | Therapeutics | Women's Health
NIH invests $150 million in human-based research to reduce use of animal models
On Mar. 18, 2026, the National Institutes of Health (NIH) announced more than $150 million to develop and…
-
New Genetic Risk Score Better Predicts Diabetes, Obesity and Downstream Complications
On Mar. 16, 2026, investigators from Mass General Brigham announce they have built metabolic polygenic risk scores (PRS) for predicting…
-
Biotechnology | Disease | Imaging | Neurology | Therapeutics
RNA barcodes enable high-speed mapping of connections in the brain
On Mar. 13, 2026, a research team lead by Boxuan Zhao, a professor of cell and developmental biology…
-
ImmunityBio Achieves Milestone with Large-Scale NK Cell Production and Cryopreservation from Over 60 Healthy and Cancer Donors
On Mar. 13, 2026, ImmunityBio announced the successful completion of manufacturing engineering programs, NK2022 and NK2023, establishing a…
-
Stanley Family Foundation renews commitment to accelerate psychiatric research at Broad Institute
On Mar. 12, 2026, the Stanley Family Foundation renewed its commitment to psychiatric research at the Broad Institute,…
-
Biotechnology | Diagnostics | Medical Device | Medicine | Neurology | Non-Profit Research | Oncology | Pharmaceutical | Radiology | Therapeutics
Mass General Brigham Receives Transformative $50 Million Gift to Shape Future of Cancer Research
On Mar. 12, 2026, Mass General Brigham (MGB) announced it has received a $50 million gift that will…
-
Researchers Develop New Way to Safely Insert Gene-Sized DNA Into the Genome
On Mar. 11, 2026, taking a step towards developing genetic therapies at scale, researchers from Mass General Brigham…
-
FDA Issues Emergency Use Authorization for Topical Spray to Prevent and Treat New World Screwworm in Multiple Species
On Mar. 10, 2026, the U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for…
-
New Study Exposes Hidden Alzheimer’s “Hot Spots” in Rural Maryland and What They Reveal About America’s Growing Healthcare Divide
On Mar. 8, 2026, a new statewide spatial analysis of Alzheimer’s disease and related dementias (ADRD) has uncovered…
-
U.S. FDA Approves Bristol Myers Squibb’s Sotyktu® (deucravacitinib) for Treatment of Adults with Psoriatic Arthritis
On Mar. 6, 2026, Bristol Myers Squibb announced that the U.S. Food and Drug Administration (FDA) has approved…
-
Sumitomo Receives Approval for world’s first iPS cell‑derived regenerative medicine in Japan
On Mar. 6, 2026, Sumitomo Pharma announce it has obtained conditional and time‑limited approval in Japan for the…
-
Tubulin prevents toxic protein clumps in the brain, fighting back neurodegeneration
On Mar. 6, 2026, researchers at Baylor College of Medicine announced they have discovered a potential new strategy…
